A public offering of common stock and warrants has brought in $26.5 million for NeuroMetrix, maker of the Quell wearable pain relief device. The proceeds will be used for commercializing the company's device, buying back 19,450 shares of Series D convertible preferred stock, retiring warrants and supporting general corporate functions.
A Series C financing round co-led by Valiance and RMM has brought in $26.5 million for Irvine, Calif.-based JenaValve Technology. The firm will use the money to advance its replacement heart valve and support its growth in the worldwide transcatheter aortic valve implants market.
A joint funding round has brought in $26.5 million for sister firms 480 Biomedical and Arsenal Medical. Arsenal plans to use its $16 million funding for the creation of a nanofiber drug delivery technology and an acute abdominal hemorrhaging treatment. The $10.5 million that 480 Biomedical raised will be used for designing a bioresorbable scaffold for patients with occlusive disease in the superficial femoral artery.
Minneapolis is weighing a possible sale of retail center Gaviidae I to a New York company that is offering $26.5 million. The city owns a 34% stake in the center, with the remaining stake owned by Brookfield Properties. The city will review the offer July 9.
Cedar Shopping Centers has acquired Cross Keys Place in Sewell, N.J., for $26.5 million. It purchased the retail center on behalf of its joint venture with RioCan Real Estate Investment Trust. Cross Keys Place is anchored by Sports Authority, Bed, Bath & Beyond, AC Moore, Old Navy and Petco.